Literature DB >> 20434223

ABO blood type as a risk factor for secondary post-tonsillectomy haemorrhage.

David S Leonard1, John E Fenton, Stephen Hone.   

Abstract

INTRODUCTION: Blood type-O is associated with decreased expression of von Willebrand factor. Type-O patients suffer fewer thrombotic problems and may be more prone to haemorrhage. Secondary post-tonsillectomy haemorrhage is the most common severe complication of tonsillectomy. We propose that type-O blood may be over-represented in patients presenting with secondary bleeds.
METHODS: We reviewed patients treated in the Royal Victoria Eye and Ear Hospital and the Midwestern Regional Hospital for secondary post-tonsillectomy haemorrhages from 2001 to 2006.
RESULTS: Three-hundred and three patients suffered secondary post-tonsillectomy haemorrhages over the study period. Blood group data was available in 206 cases (68%). Sixty-three percent of patients studied were blood group O, compared with 55% of the general population (p=0.01).
CONCLUSIONS: Blood group O is disproportionately represented in secondary post-tonsillectomy haemorrhage patients. Although we cannot demonstrate causality, this association suggests that patients with type-O blood are more likely to suffer from secondary bleeds following tonsillectomy. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20434223     DOI: 10.1016/j.ijporl.2010.03.003

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  2 in total

1.  O blood type is a risk factor for upper gastrointestinal bleeding.

Authors:  Massimo Franchini; Thomas Togliani; Rosalia Turdo; Giuseppe Lucchini; Carlo Bonfanti; Ivano Giacomini; Mario Luppi; Stefano Pilati
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

2.  The Impact of Tobacco Smoking Upon Chronic/Recurrent Tonsillitis and Post Tonsillectomy Bleeding.

Authors:  Udi Cinamon; Abraham Goldfarb; Tal Marom
Journal:  Int Arch Otorhinolaryngol       Date:  2016-10-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.